Laura Mazzeo

6PUBLICATIONS
35CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Context learningMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2026
Alectinib and gastrointestinal perforation in ALK-rearranged non-small cell lung cancer: A case series.

|Nov 24, 2025
Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records.

Federica Corso, Vittoria Peppoloni, Laura Mazzeo

|Apr 16, 2024
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs.

Rita Leporati, Daniela Miliziano, Teresa Beninato

|Feb 19, 2024
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.

Luigi Cerbone, Sara Delfanti, Stefania Crivellari

|Aug 04, 2022
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center.

Giovanni Fucà, Mara Lecchi, Chiara Maura Ciniselli

|Dec 18, 2020
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis.

Riccardo Lobefaro, Emma Zattarin, Federico Nichetti

Pageof 1

Frequent Collaborators

4 joint publications

Mario Occhipinti

2 joint publications

Teresa Beninato

2 joint publications

Marta Brambilla

1 joint publications

Riccardo Lobefaro